Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts

<p>Abstract</p> <p>Background</p> <p>Osteoprotegerin (OPG) has been reported to prevent bone resorption by inhibiting the formation, function, and survival of osteoclasts in a variety of animal models. However, the effects of OPG on bone metabolism in avian species have...

Full description

Bibliographic Details
Main Authors:	Yao Jing, Hou Jiafa, Hou Lele, Zhou Zhenlei
Format:	Article
Language:	English
Published:	BMC 2011-03-01
Series:	Acta Veterinaria Scandinavica
Online Access:	http://www.actavetscand.com/content/53/1/21

Similar Items

Biosafety, and improvement of osteoporosis in cage layers through using chOPG protein
by: Lele Hou, et al.
Published: (2020-01-01)

In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression
by: Xu Li, et al.
Published: (2010-02-01)

Protein Expression of Mesenchymal Stem Cells after Transfection of pcDNA3.1−-hVEGF165 by Ultrasound-Targeted Microbubble Destruction
by: Zhaoxia Pu, et al.
Published: (2011-01-01)

Construction of pcDNA3.1 Vector Encoding rpfD Gene of Mycobacterium tuberculosis
by: Aprilia Rakhmawati, et al.
Published: (2018-09-01)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
by: Lili Zhang, et al.
Published: (2016-11-01)

Generation of uncleavable Slit2 construct in pcDNA vector
by: Chi-Hsiung, et al.
Published: (2008)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
by: Gamal B Mohamed, et al.
Published: (2011-01-01)

Construction of pcDNA3.1-FSHβ expression vector in order to transfer FSHβ gene into a mammalian cellline
by: Reza Nasr, et al.
Published: (2013-06-01)

Evaluation of the Immune Response Against Helicobacter pylori in Infused BALB/c Mice by pcDNA3.1(+)-ureA&nbsp;
by: Maryam Nasr-Esfahani, et al.
Published: (2020-03-01)

Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.
by: Wei Liu, et al.
Published: (2015-01-01)

The Function of Naringin in Inducing Secretion of Osteoprotegerin and Inhibiting Formation of Osteoclasts
by: Tong Xu, et al.
Published: (2016-01-01)

Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation
by: WANG Xin, et al.
Published: (2013-10-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

Construction of pcDNA3.1-CD74-ROS1 Recombinant Plasmid and Effect of CD74-ROS1 Expression on Proliferation and Migration of Lung Cancer Cells
by: WU Yazhou, et al.
Published: (2018-04-01)

Antitumor activity of intratumoral injection of pcDNA3.1-p27Kip1mt followed by in vivo electroporation in a malignant Burkitt’s lymphoma cell xenograft
by: Supriatno Supriatno, et al.
Published: (2012-12-01)

Electro-gene therapy in a human oral tongue cancer cell by intratumoral injection of pcDNA3.1-p27<sup>Kip1</sup> wt
by: Supriatno Supriatno
Published: (2007-03-01)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021-11-01)

Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
by: Binghan Li, et al.
Published: (2016-04-01)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
by: Holen Ingunn, et al.
Published: (2009-07-01)

Electro-gene therapy followed by intratumoral injection of pcDNA3.1-p27Kip1 wild type in human tongue base cancer cells SP-C3 xenograft
by: S. Supriatno, et al.
Published: (2009-11-01)

Abstract: Osteoprotegerin-Mediated Osteoclast Inhibition Is Augmented on Nanoparticulate Mineralized Collagen Glycosaminoglycan Materials
by: Justine C. Lee, MD, PhD, et al.
Published: (2018-09-01)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL / RANK and osteoprotegerin (OPG) system
by: Charalampos Skarlis, et al.
Published: (2018-01-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
by: Martin Widschwendter, et al.
Published: (2015-10-01)

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
by: Peggy Benad-Mehner, et al.
Published: (2014-03-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
by: Yosra Azizpour, et al.
Published: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
by: Yosra Azizpour, et al.
Published: (2020-01-01)

Determinant Factors and Added Value of Osteoprotegerin (OPG) to Detect Carotid Intima-Media Thickness (CIMT) in Type 2 Diabetes Mellitus Patient
by: Shirly Elisa Tedjasaputra, et al.
Published: (2018-06-01)

Effect of Bitter Compounds on the Expression of Bitter Taste Receptor T2R7 Downstream Signaling Effectors in cT2R7/pDisplay-Gα16/gust44/pcDNA3.1 (+) Cells
by: Yuan Su, et al.
Published: (2019-01-01)

Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) expression in lipopolysaccharide-induced rat periapical lesions
by: Fu-Hsiung Chuang, et al.
Published: (2013)

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
by: Lane Denis, et al.
Published: (2012-11-01)

Structural changes and the differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kB ligand (RANKL) in subchondral bone during the development of osteoarthritis
by: Akma Azmiera Akman, et al.
Published: (2018)

Expression of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) on root surface after different extra-oral dry times
by: Tang, Kok Siew
Published: (2012)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
by: Sheng Zhu, et al.
Published: (2021-12-01)

Osteoporotic bone of miR-150-deficient mice: Possibly due to low serum OPG-mediated osteoclast activation
by: Sik-Won Choi, et al.
Published: (2015-12-01)

Changes of gingival fluid volume, receptor activator of NF-kappa B ligand (RANKL), osteoprotegerin(OPG) and total protein during human orthodontic tooth movement
by: Shen-Chieh Lin, et al.
Published: (2006)

Sistema osteoprotegerin (OPG) -ligand retseptora-aktivatora yadernogo faktora kappa-V (RANKL) pri diabeticheskoy neyroosteoartropatii i obliteriruyushchem ateroskleroze arteriy nizhnikh konechnostey
by: Марианна Viktorovna Yaroslavtseva, et al.
Published: (2007-06-01)

IL-15 deficiency alleviates steroid-induced osteonecrosis of the femoral head by impact osteoclasts via RANKL-RANK-OPG system
by: Zubin Zhou, et al.
Published: (2020-06-01)

Establishment of OPG Transgenic Mice and the Effect of OPG on Bone Microarchitecture
by: Ying Wu, et al.
Published: (2013-01-01)

Stability of gag-ca gene of Jembrana Virus in pcDNA-ca recombinant plasmid vector in Escherichia coli DH5α which has been stored for eight years
by: Baso Yusuf, et al.
Published: (2015-06-01)

The study on the stimulation of the immune system in the infused BALB/C mice by pCDNA3.1(-)-flaA recombinant vector against Helicobacter pylori infection using molecular techniques
by: Ramazani-Dehnavi Behrouz, et al.
Published: (2018-01-01)